Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori (Helipro)
Prospective Analysis of the Eradication Percentage of Helicobacter Pylori, to Evaluate the Effect of Standardized Eradication Schemes and Active Communication With the General Practitioner and Patient.
Sponsor: Algemeen Ziekenhuis Maria Middelares
This observational or N/A phase trial investigates Helicobacter Pylori Infection and is currently completed. Algemeen Ziekenhuis Maria Middelares leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2019 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Sep 2018 — Apr 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Algemeen Ziekenhuis Maria Middelares
For direct contact, visit the study record on ClinicalTrials.gov .